As of 2025-11-01, the EV/EBITDA ratio of Insmed Inc (INSM) is -43.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 39,355.52 mil USD. INSM's TTM EBITDA according to its financial statements is -908.56 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 15.9x | 15.7x |
| Forward P/E multiples | 14.9x - 15.6x | 15.5x |
| Fair Price | (62.01) - (63.56) | (63.65) |
| Upside | -132.7% - -133.5% | -133.6% |
| Date | EV/EBITDA |
| 2025-10-30 | -44.39 |
| 2025-10-29 | -38.05 |
| 2025-10-28 | -37.66 |
| 2025-10-27 | -37.37 |
| 2025-10-24 | -36.35 |
| 2025-10-23 | -36.46 |
| 2025-10-22 | -36.52 |
| 2025-10-21 | -37.67 |
| 2025-10-20 | -38.27 |
| 2025-10-17 | -37.77 |
| 2025-10-16 | -37.17 |
| 2025-10-15 | -37.25 |
| 2025-10-14 | -36.75 |
| 2025-10-13 | -37.35 |
| 2025-10-10 | -36.97 |
| 2025-10-09 | -37.45 |
| 2025-10-08 | -36.85 |
| 2025-10-07 | -36.97 |
| 2025-10-06 | -36.03 |
| 2025-10-03 | -35.77 |
| 2025-10-02 | -34.76 |
| 2025-10-01 | -33.47 |
| 2025-09-30 | -32.71 |
| 2025-09-29 | -32.16 |
| 2025-09-26 | -31.09 |
| 2025-09-25 | -30.75 |
| 2025-09-24 | -32.01 |
| 2025-09-23 | -33.03 |
| 2025-09-22 | -32.95 |
| 2025-09-19 | -32.88 |
| 2025-09-18 | -33.14 |
| 2025-09-17 | -32.89 |
| 2025-09-16 | -32.88 |
| 2025-09-15 | -32.51 |
| 2025-09-12 | -33.16 |
| 2025-09-11 | -33.12 |
| 2025-09-10 | -33.16 |
| 2025-09-09 | -33.45 |
| 2025-09-08 | -33.33 |
| 2025-09-05 | -32.96 |
| 2025-09-04 | -32.37 |
| 2025-09-03 | -32.59 |
| 2025-09-02 | -33.01 |
| 2025-08-29 | -30.87 |
| 2025-08-28 | -30.61 |
| 2025-08-27 | -30.50 |
| 2025-08-26 | -29.96 |
| 2025-08-25 | -29.06 |
| 2025-08-22 | -29.89 |
| 2025-08-21 | -30.06 |